Investing.com - Collplant ADR reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Collplant ADR announced earnings per share of $-0.39 on revenue of $66K. Analysts polled by Investing.com anticipated EPS of $-0.07 on revenue of $2.86M.
Collplant ADR shares are down 61% from the beginning of the year, still down 65.26% from its 52 week high of $23.00 set on November 16, 2021. They are under-performing the OMX Helsinki 25 which is down 13.84% from the start of the year.
Collplant ADR shares lost 0.75% in intra-day trade following the report.
Collplant ADR follows other major Healthcare sector earnings this month
Collplant ADR's report follows an earnings missed by Eli Lilly on August 4, who reported EPS of $1.25 on revenue of $6.49B, compared to forecasts EPS of $1.7 on revenue of $6.85B.
Pfizer had beat expectations on July 28 with second quarter EPS of $2.04 on revenue of $27.74B, compared to forecast for EPS of $1.72 on revenue of $25.49B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar